Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant
Acutely Painful Shoulder – Assessment and Management in GP
Dr Richard Phoon
Chronic Kidney Disease – Delay Progression and Prevent Dialysis
Prof Rodney Baber AM
Understand & Explain the Risks & Side Effects of MHT
Prof Peter Richmond
Invasive Pneumococcal Disease – What GPs Need to Know
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
